Stay updated on Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added to the page header. Revision: v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T11:20:03.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Padova, Italy, 35128 and removed Padua, Italy, 35128 from the location list. The entry now uses the Italian spelling for the site.
    Difference
    0.0%
    Check dated 2026-04-09T08:44:53.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 as a study location and removed Napoli, Italy, 80131.
    Difference
    0.0%
    Check dated 2026-03-26T02:53:08.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added Melanoma and related topics (MedlinePlus Genetics) and updated site revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T20:37:43.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T20:00:19.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Removed the Melanoma condition tag and the MedlinePlus Genetics related topic link from the study page.
    Difference
    0.1%
    Check dated 2026-03-04T15:24:53.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.